Objective: The early diagnosis of acromegaly is critical to successful treatment AH and prevention of complications. Design and method: We present the case of a 47-year-old man with RAH (BP 180/100-110) mmHg treated with olmesartan 40, hydrochlorothiazide 25, amlodipin 10 mg/day. Increased BP is observed from the age of 20. At the age of 41 he suffered an ischemic stroke. Concomitant diseases: diabetes mellitus, obstructive sleep apnea syndrome (on CPAP therapy), chronic kidney disease stage 2, obesity (BMI 37 kg/m2), dyslipidemia. Results: Early onset of hypertension, enlargement of the extremities and tongue over the past few years led to the suspicion of secondary hypertension. Growth hormone (1550 ng/mL, reference values <1 ng/mL), insulin-like growth factor-1 (454 ng/mL, reference values 53-215 ng/mL) were determined. MRI of the pituitary gland without contrast 6 years ago did not reveal any pituitary pathology, with contrast - microadenoma. The patient was recommended a surgery treatment. Conclusions: Late diagnosis of acromegaly led to multiple complications in the patient. It is necessary to identify target groups of patients for early detection of acromegaly, which will help prevent complications that develop at it progresses.
Bezrodnyi et al. (Fri,) studied this question.